Key Pharma News Issue - Roche Willing to Pay Out For Innovation - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Key Pharma News Issue 52" report to their offering.

The current unmet medical need in influenza treatment creates a favourable commercial environment for MedImmune to enter. The US ageing population creates a sustained and growing patient base that will serve to drive considerable growth for effective anti-influenza medications. The introduction of a universal flu vaccine would serve to cap sales considerably, but development is still in its infancy.

Key Topics Covered:

1. Agreements

  • Innovation And Differentiation Will Drive Change For GSK

2. Corporate Activity

  • Towards Harmonising Transatlantic Review Times
  • Sanofi/Merck To End European Joint Vaccines Operations
  • Teva Acquisition Of Allergan Generics Edges Closer With Key European Approval

3. Product News

  • Fast-Paced Treatment Optimisation Will Continue To Drive Up Cancer Drug Spend
  • Pfizer's Xalkori Granted FDA Approval For ROS1-Positive Metastatic NSCLC
  • Celgene Receives Paclitaxel ANDA Notice
  • More Work Necessary For WHO To Break Biosimilar Naming Stalemate
  • Novel CF Drug Will Secure Market For Vertex Despite High Cost
  • Teva Canada Launches Abacavir+Lamivudine

4. R&D

  • Zydelig Woes Underscore Need For Scale-Up In Diversification Efforts
  • CNS Breakthroughs Slowing Despite Increasing Demand
  • Idelvion Approval Will Bolster CSL Behring's Rare Disease Portfolio

For more information visit http://www.researchandmarkets.com/research/jg738r/key_pharma_news

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals